Skip to content
Clinical Trials – home

HER2 negative breast cancer Life with Disease

Clinical trials for HER2 negative breast cancer

Recruiting trials first

See all 10 trials →
Quick filters

10 clinical trials in this condition

Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Institut Paoli-Calmettes

Breast cancer+2

Not yet recruiting

Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Orszagos Onkologiai Intezet

Breast cancer+4

Not recruiting

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Institut fuer Frauengesundheit GmbH

B-cell lymphoma+13

Not recruiting

Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fadraciclib
  • Sponsor:Cyclacel Limited
See all 10 trials →filters applied: condition = HER2 negative breast cancer

In short

HER2 negative breast cancer is the most common form of breast cancer, accounting for about 80% of all diagnosed cases. This type occurs when cancer cells in the breast do not produce high levels of a protein called HER2, which normally helps control cell growth and repair. Understanding this diagnosis and its implications can help patients and their families navigate treatment decisions and plan for the future with greater confidence.

Key points

  • HER2 negative breast cancer accounts for about 80% of all breast cancer cases and is generally less aggressive than HER2 positive types
  • Your HER2 status must be determined through laboratory testing of tumor tissue and cannot be identified through physical examination alone
  • Most HER2 negative breast cancers (70%) are also hormone receptor positive, meaning they respond to hormone-blocking treatments
  • Triple negative breast cancer, which lacks HER2 and both hormone receptors, requires different treatment approaches and tends to be more aggressive
  • Treatment options for HER2 negative breast cancer include surgery, chemotherapy, radiation, hormone therapy, and targeted therapies depending on your specific cancer characteristics
  • Living with HER2 negative breast cancer affects physical health, emotional well-being, relationships, work life, and daily routines in ways that extend beyond medical treatment
  • Family members can provide crucial support by attending appointments, helping with research about treatment options including clinical trials, and offering emotional encouragement
  • Self-care during treatment includes managing physical symptoms, addressing emotional health, maintaining social connections, and finding ways to continue activities that bring joy

Understanding Your Outlook with HER2 Negative Breast Cancer

Learning that you have HER2 negative breast cancer can feel overwhelming, but it's important to know that this diagnosis often comes with a more hopeful outlook compared to HER2 positive cancers. The prognosis for HER2 negative breast cancer varies significantly depending on several factors that your healthcare team will carefully evaluate.

When doctors talk about prognosis, they're referring to the likely course and outcome of your disease. For HER2 negative breast cancer, the outlook depends largely on whether your cancer is also positive for hormone receptors like estrogen or progesterone. About 70% of HER2 negative breast cancers are hormone receptor positive, meaning they grow in response to these hormones. These cancers tend to respond well to hormone-blocking treatments and generally have a favorable outlook.

The remaining 11% of HER2 negative cases are triple negative, meaning they lack HER2 proteins and both hormone receptors. Triple negative breast cancer is typically more aggressive and requires different treatment approaches. However, advances in medical research continue to improve outcomes for all types of HER2 negative breast cancer.

Your stage at diagnosis plays a critical role in determining your prognosis. When breast cancer is caught early, before it has spread beyond the breast or nearby lymph nodes, survival rates are significantly higher. This is why regular screening and early detection remain so important. Your doctor will also consider factors like the size of your tumor, whether cancer cells have reached your lymph nodes, how fast the cancer cells are growing, and your overall health when discussing your individual outlook.

How the Disease Progresses Without Treatment

Understanding what happens if HER2 negative breast cancer goes untreated is important for appreciating why early intervention matters. Without treatment, cancer cells that begin in the breast tissue continue to divide and multiply, forming larger tumors over time.

In the early stages, a small cluster of abnormal cells may remain confined to the milk ducts or lobules of the breast. As time passes without intervention, these cells can break through the walls of these structures and invade surrounding breast tissue. This transition from noninvasive to invasive cancer marks a significant change in how the disease behaves and spreads.

As the tumor grows larger, cancer cells can enter nearby lymph nodes, particularly those in the armpit area. The lymphatic system acts like a highway network throughout your body, and once cancer cells gain access to this system, they can travel to distant organs. Common sites where breast cancer spreads include the bones, liver, lungs, and brain.

The speed at which HER2 negative breast cancer progresses varies from person to person. Hormone receptor positive, HER2 negative cancers often grow more slowly than triple negative types. However, even slow-growing cancers will eventually advance without treatment, which is why doctors emphasize the importance of not delaying care once a diagnosis is made.

Possible Complications and Challenges

HER2 negative breast cancer can lead to various complications, both from the disease itself and sometimes from its treatment. Understanding these potential challenges helps you and your healthcare team watch for warning signs and address problems early.

When cancer spreads to the lymph nodes in your armpit, it can disrupt the normal flow of lymph fluid. This can lead to a condition called lymphedema, where your arm, hand, or chest area swells because fluid builds up in the tissues. Lymphedema can develop during or even years after treatment, particularly if lymph nodes are removed during surgery or damaged by radiation therapy. The swelling can be uncomfortable and may limit your range of motion.

If breast cancer spreads to other parts of your body, it becomes what doctors call metastatic breast cancer. This is the most serious complication because cancer in distant organs is much harder to eliminate completely. When breast cancer spreads to the bones, it can cause pain, fractures, and elevated calcium levels in your blood. Cancer in the liver can affect how your body processes nutrients and medications. Lung metastases may cause breathing difficulties and persistent coughing. Brain metastases can lead to headaches, seizures, or changes in mental function.

Some patients develop side effects from their cancer treatments that become complications in their own right. Chemotherapy can weaken your immune system, making you more vulnerable to infections. Hormone therapy may trigger menopausal symptoms like hot flashes, mood changes, and bone thinning. Radiation can cause skin changes and fatigue. Surgery carries risks of infection, bleeding, and complications from anesthesia.

Cancer and its treatment can also affect your heart health, a complication that may not appear until months or years later. Some chemotherapy drugs can damage heart muscle, and radiation to the left breast may affect the nearby heart tissue. Your medical team will monitor your heart function if you receive treatments known to carry these risks.

Impact on Your Daily Life and Well-Being

Living with HER2 negative breast cancer affects far more than just your physical health. The disease and its treatment can reshape nearly every aspect of your daily routine, relationships, and sense of self.

Physically, you may experience fatigue that goes beyond normal tiredness. This cancer-related exhaustion can make even simple tasks feel overwhelming. You might need to rest more frequently throughout the day and may find that you cannot maintain the same activity level you once did. Treatment side effects like nausea, pain, or hot flashes from hormone therapy can interrupt sleep and make it harder to focus on work or hobbies.

Your work life may require adjustments. Some people continue working throughout treatment, while others need to reduce their hours or take medical leave. This depends on the type of work you do, the intensity of your treatment schedule, and how your body responds. Frequent medical appointments for chemotherapy, radiation, or check-ups can make maintaining a regular work schedule challenging. You may need to have honest conversations with your employer about flexibility and accommodations.

Emotionally, a breast cancer diagnosis can trigger anxiety, fear, sadness, and uncertainty about the future. You might worry about your prognosis, how treatment will affect you, or the financial burden of cancer care. These feelings are completely normal and valid. Many patients find that their emotional state fluctuates throughout their cancer journey, with some days feeling more hopeful than others.

Your relationships with family and friends may shift as well. Some people become closer to loved ones during this time, while others feel isolated or misunderstood. Partners may struggle with their own fears about your illness while trying to provide support. Children, depending on their age, may have difficulty understanding what's happening and why a parent is sick. Open communication about your needs and feelings can help maintain strong connections during this difficult period.

Body image concerns often arise, especially if treatment involves surgery that changes the appearance of your breasts. Whether you have a lumpectomy that removes part of the breast or a mastectomy that removes the entire breast, adjusting to physical changes takes time. Hair loss from chemotherapy can also affect how you see yourself. These changes can impact your self-esteem and intimate relationships.

Financial stress is another reality for many cancer patients. Medical bills, insurance co-pays, prescription costs, and lost income from missed work can create significant financial strain. Some people must also pay for transportation to treatment centers, childcare, or home help during recovery periods. Financial concerns add another layer of stress to an already challenging situation.

Despite these challenges, many patients find ways to adapt and maintain quality of life. Breaking tasks into smaller, manageable pieces can help when energy is low. Accepting help from others, whether with household chores, meal preparation, or childcare, can ease your burden. Finding new ways to enjoy hobbies, even if you must modify them, helps maintain a sense of normalcy. Connecting with other cancer patients who understand what you're going through can provide valuable emotional support and practical advice.

Supporting Your Family Through Clinical Trials

When you have HER2 negative breast cancer, you and your family might hear about clinical trials as a treatment option. Understanding what these trials involve and how your loved ones can support you through this process is valuable knowledge to have.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For HER2 negative breast cancer, these trials might study new chemotherapy drugs, innovative hormone therapies, immunotherapy approaches, or novel targeted treatments. Some trials compare standard treatments with new options to see which works better.

Your family should know that participating in a clinical trial is always voluntary. You have the right to join or decline, and you can withdraw from a trial at any time without affecting your regular care. Trials have strict rules about who can participate, based on factors like your cancer type, stage, previous treatments, and overall health. Not everyone who wants to join a trial will qualify.

Family members can help by attending appointments with you when clinical trials are discussed. Having another person there to listen, ask questions, and take notes is extremely helpful because medical information can be overwhelming. Your loved ones can help you understand the potential benefits and risks of trial participation, compare the trial option with standard treatment, and think through how the trial requirements might affect your daily life.

If you decide to join a clinical trial, your family can provide practical support in several ways. They can help keep track of your appointment schedule, which may be more frequent in a trial than with standard treatment. They can watch for and report any side effects or changes in your condition. They can assist with transportation to the trial center, which might be farther from home than your regular cancer center.

Emotional support is equally important. Your family can remind you why you chose to participate in the trial when things get difficult. They can celebrate the contribution you're making to medical research that may help future patients. They can be there to listen when you need to talk about your experiences or concerns.

Finding clinical trials requires some research. Your oncologist may know about trials that match your situation, but you can also search online databases of active trials. Your family can help with this research, looking for trials in your area or even in other locations if you're willing and able to travel. They can contact trial coordinators to ask preliminary questions and gather information packets.

Your relatives should understand that being in a clinical trial doesn't mean giving up standard care. Many trials compare a new treatment added to standard therapy versus standard therapy alone. Others test whether a new drug works as well as the standard treatment but with fewer side effects. The trial protocol will clearly explain what treatments you'll receive.

Family members should also know about your rights as a trial participant. You must give informed consent, meaning the research team fully explains the study before you agree to join. You can ask as many questions as you need. You'll receive regular monitoring and care throughout the trial. If the trial treatment causes serious side effects, you can stop participating. All of this information should be clearly explained in the consent documents.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Anastrozole (Arimidex) – An aromatase inhibitor that lowers estrogen levels to slow the growth of hormone receptor positive breast cancer
  • Exemestane (Aromasin) – An aromatase inhibitor used to reduce estrogen production in hormone receptor positive breast cancer
  • Letrozole (Femara) – An aromatase inhibitor that blocks estrogen production to treat hormone receptor positive breast cancer
  • Fulvestrant (Faslodex) – A hormone therapy that blocks estrogen from connecting to cancer cells
  • Tamoxifen (Nolvadex, Soltamox) – A hormone therapy that prevents estrogen from binding to cancer cells
  • Toremifene (Fareston) – A hormone therapy medication that blocks estrogen receptors
  • Goserelin (Zoladex) – A medication that stops the body from making estrogen
  • Leuprolide (Lupron) – A drug that reduces estrogen production in the body
  • Olaparib (Lynparza) – A PARP inhibitor that prevents cancer cells from repairing themselves, used for patients with BRCA gene mutations
  • Talazoparib (Talzenna) – A PARP inhibitor that stops cancer cell repair in patients with BRCA mutations
  • Capivasertib (Truqap) – A targeted therapy that blocks AKT proteins involved in cancer cell growth

Did you know?

  1. About 4 out of 5 breast cancers are HER2 negative, making it far more common than HER2 positive breast cancer.
  2. HER2 negative breast cancer is actually less aggressive than HER2 positive cancer because it lacks the excess protein that drives rapid tumor growth.
  3. Your cancer's HER2 status can only be determined through laboratory testing of tumor tissue – doctors cannot tell by physical examination alone.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.